Abthrax (raxibacumab) / Emergent Biosolutions 
Welcome,         Profile    Billing    Logout  
 5 Diseases   1 Trial   1 Trial   29 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Abthrax (raxibacumab) / Emergent Biosolutions
NCT02177721: Clinical Benefit, Safety and PK of Raxibacumab in Subjects Exposed to Bacillus Anthracis

Not yet recruiting
4
100
NA
Collection of samples
Emergent BioSolutions, Centers for Disease Control and Prevention, Department of Health and Human Services, GlaxoSmithKline
Infections, Bacterial
07/25
07/25

Download Options